Related Experiment Video
Updated: Nov 22, 2025

Screening Bioactive Nanoparticles in Phagocytic Immune Cells for Inhibitors of Toll-like Receptor Signaling
Published on: July 26, 2017
[Toll-like Receptor Agonists in Radiation Protection]
Jiao Guo1, Hai Yu Yang1, Wei Long1
1Department of Pharmaceutica,Institute of Radiation Medicine,CAMS and PUMC,Tianjin 300192,China.
High-efficiency, low-toxicity radiation protection drugs are needed due to ionizing radiation damage. Toll-like receptor agonists show promise for radioprotection by activating pathways like nuclear factor-κB, informing new drug development.
Area of Science:
- Biomedical Sciences
- Pharmacology
- Radiation Biology
Background:
- Ionizing radiation induces significant apoptosis in human tissue cells, impairing gastrointestinal and hematopoietic functions.
- There is a critical need for effective and safe radioprotective agents to mitigate radiation-induced damage.
- Toll-like receptor agonists have emerged as potential radioprotectors, leveraging tumor cell anti-apoptotic mechanisms.
Purpose of the Study:
- To elucidate the role of various Toll-like receptor agonists in radiation protection.
- To provide insights for the development of novel radioprotective drugs.
- To explore the anti-apoptotic mechanisms underlying Toll-like receptor agonist-mediated radioprotection.
Main Methods:
- Review and analysis of existing literature on Toll-like receptor agonists and their effects on radiation-induced apoptosis.
- Investigation of downstream signaling pathways activated by Toll-like receptor agonists, particularly nuclear factor-κB.
- Evaluation of the radioprotective efficacy and toxicity profiles of identified agonists.
Main Results:
- Several Toll-like receptor agonists demonstrate significant radioprotective potential.
- Activation of nuclear factor-κB and other downstream pathways is a key mechanism for radioprotection.
- The anti-apoptotic effects observed in tumor cells can be translated to protective effects in normal tissues.
Conclusions:
- Toll-like receptor agonists represent a promising class of compounds for developing new radiation protection strategies.
- Targeting Toll-like receptor pathways offers a viable approach to enhance cellular resistance to ionizing radiation.
- Further research into specific agonists and their mechanisms is warranted for clinical translation.
Related Concept Videos
Tumor Immunotherapy
Biological Effects of Radiation
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Radiation: Applications
The average...
Receptor Tyrosine Kinases
Signal Transduction: Overview
Typically, signal transduction involves three...

